Download the whitepaper to gain insights that can help inform your manufacturing
approach.
Drug pipelines are evolving rapidly, with increasing focus on highly potent APIs,
targeted therapies, and complex oral solid dose (OSD) formulations. As development
complexity grows, manufacturing strategy has become a critical factor in bringing new
medicines to market efficiently.
In this whitepaper, “Placing drug strategies on a solid foundation for success,” explore
the industry trends influencing pharmaceutical outsourcing and commercial manufacturing
decisions today.
Download the whitepaper to discover:
Powered by Pfizer expertise, Pfizer CentreOne provides commercial manufacturing capabilities designed to help pharmaceutical companies navigate complex OSD requirements and support their drug commercialization strategies.